Stock AnalizRyan Specialty Holdings, Inc. RYAN
Specialty Insurers · IPO 2021 · data as of November 13, 2026
Ryan Specialty Holdings, Inc. (RYAN) is a financial company listed in the US with a market value of about $11.8B. In the twelve months to September 30, 2026 it had revenue of $3.2B and net income of $105M, a net margin of 3.3%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a P/E of 60.1, a price to free cash flow of 20.7, 5-year revenue growth of 25% a year, a 5-year average ROIC of 9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 84% below the current price.
Score: 2.0 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- Positive free cash flow
- Interest covered more than 5 times
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.1B | $2.5B | $2.1B | $1.7B | $1.4B | $1.0B | $765M |
| Net income | $105M | $63M | $95M | $61M | $61M | $66M | $68M | $64M |
| Free cash flow | $569M | $641M | $515M | $477M | $328M | -$70M | $130M | $149M |
| EPS (diluted) | $0.78 | $0.25 | — | — | — | — | — | — |
| Net margin | 3.3% | 2.1% | 3.8% | 2.9% | 3.5% | 4.6% | 6.7% | 8.4% |
| ROIC | — | 8.6% | 8.8% | 10.8% | 10.0% | 7.5% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 16 analysts is $48.78, 4% above the current price; targets range from $40.00 to $68.00; the consensus rating is “Buy”; expected EPS is $2.18 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Ryan Specialty’s P/E ratio?
About 60.1, based on the last twelve months of diluted earnings per share (forward P/E about 21.2).
Is Ryan Specialty stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 84% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Ryan Specialty pay a dividend?
Yes. The dividend yield is about 1.11%, and it has paid dividends for 2 years in our data.
Is Ryan Specialty a good stock to buy?
We do not give buy or sell advice. Ryan Specialty scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.